Sofia Bougioukli to Bone Morphogenetic Protein 2
This is a "connection" page, showing publications Sofia Bougioukli has written about Bone Morphogenetic Protein 2.
Connection Strength
3.335
-
Ex vivo gene therapy using human bone marrow cells overexpressing BMP-2: "Next-day" gene therapy versus standard "two-step" approach. Bone. 2019 11; 128:115032.
Score: 0.646
-
Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells. Hum Gene Ther. 2019 07; 30(7):906-917.
Score: 0.633
-
In vitro evaluation of a lentiviral two-step transcriptional amplification system using GAL4FF transactivator for gene therapy applications in bone repair. Gene Ther. 2018 07; 25(4):260-268.
Score: 0.597
-
Gene Therapy for Bone Repair Using Human Cells: Superior Osteogenic Potential of Bone Morphogenetic Protein 2-Transduced Mesenchymal Stem Cells Derived from Adipose Tissue Compared to Bone Marrow. Hum Gene Ther. 2018 04; 29(4):507-519.
Score: 0.587
-
Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. Bone. 2016 Mar; 84:93-103.
Score: 0.503
-
Ex vivo regional gene therapy with human adipose-derived stem cells for bone repair. Bone. 2020 09; 138:115524.
Score: 0.172
-
Regulated ex vivo regional gene therapy for bone repair using an inducible caspase-9 suicide gene system. Gene Ther. 2019 06; 26(6):230-239.
Score: 0.158
-
Cryopreservation of Human Adipose-Derived Stem Cells for Use in Ex Vivo Regional Gene Therapy for Bone Repair. Hum Gene Ther Methods. 2018 12; 29(6):269-277.
Score: 0.038